Idose Tr Implant
Product Images NDC 25357-100

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Idose Tr (NDC 25357-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaukos Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Idose 01)

Illustration of a gloved hand holding a white, pen-shaped medical device with a fine needle, likely used for the intracameral implantation of iDose TR, a travoprost intracameral implant by Glaukos Corporation.*

FDA Label Image

Figure-02 (Idose 02)

Illustration showing the iDose TR Travoprost Intracameral Implant delivery system. It includes a pen-like inserter device with labeled safety clip and release button. An enlarged view shows the inserter tip with grasper holding the implant, which is composed of an implant anchor and implant reservoir.*

FDA Label Image

Figure-03 (Idose 03)

An illustration showing a close-up view of a trabecular meshwork region of the eye with the iDose TR implant device positioned near the tissue. The image highlights the device's small cylindrical shape and insertion point in the intracameral space.*

FDA Label Image

Figure-04 (Idose 04)

Illustration showing the iDose TR implant, a travoprost intracameral implant, positioned inside the eye's anterior chamber angle. The image highlights the implant's placement within ocular tissue, depicting the device partially embedded into the tissue with detailed visualization of the surrounding anatomical structures.*

FDA Label Image

Figure-05 (Idose 05)

This illustration shows an intracameral implant device for the controlled release of medication inside the eye. The image focuses on a small black implant positioned near the eye's inner layers, alongside a surgical instrument presumably used for implantation or positioning.*

FDA Label Image

Figure-06 (Idose 06)

An anatomical illustration showing the iDose TR Travoprost intracameral implant positioned in the eye’s anterior chamber near the iris and cornea. The image highlights the implant's placement within ocular tissue for targeted drug delivery.*

FDA Label Image

Figure-07 (Idose 07)

Chemical structure diagram representing the active ingredient in iDose TR, Travoprost Intracameral implant, showing its molecular composition and bonds.*

FDA Label Image

Figure-07 (Idose 08)

A line graph comparing the least squares mean change from baseline in intraocular pressure (IOP) over time between iDose TR implant and Timolol eye treatment. Data points are shown for Day 10, Week 6, and Month 3 at two time points each day (8AM and 10AM). The graph illustrates slight differences in IOP reduction between the two treatments.*

FDA Label Image

Figure-08 (Idose 09)

A line graph comparing the least squares mean change from baseline in intraocular pressure (IOP) in mmHg over time between iDose TR and Timolol. Data points are shown for Day 10, Week 6, and Month 3 at both 8AM and 10AM. The graph includes numerical differences and 95% confidence intervals between iDose TR and Timolol at each time point.*

FDA Label Image

Symbol0 (Idose 10)

FDA Label Image

Symbol1 (Idose 11)

FDA Label Image

Symbol2 (Idose 12)

iDose TR 75 microgram intracameral implant label showing a lot number box. The label is from Glaukos Corporation and includes the product name and dosage information clearly displayed.*

FDA Label Image

Symbo13 (Idose 13)

FDA Label Image

Symbo14 (Idose 14)

FDA Label Image

Symbol5 (Idose 15)

FDA Label Image

Symbol6 (Idose 16)

FDA Label Image

Symbol7 (Idose 17)

A black-and-white line illustration depicting an intraocular implant delivery device shaped with a slender handle and a rounded end, indicating a surgical tool likely used for intracameral administration of an implant such as iDose TR.*

FDA Label Image

Symbol8 (Idose 18)

The image shows a sterile label with a capital letter 'R' inside a rectangular box. It is associated with the iDose TR 75 mcg Intracameral Implant by Glaukos Corporation, indicating the product is sterile and designated as 'R' for identification.*

FDA Label Image

Symbol9 (Idose 19)

Packaging label for iDose TR Travoprost Intracameral Implant 75 micrograms, a human prescription drug. The label indicates the route is intracameral and the product is labeled by Glaukos Corporation with NDC 25357-100.*

FDA Label Image

Symbol10 (Idose 20)

FDA Label Image

Symbol11 (Idose 21)

FDA Label Image

75 Mcg Lid Label (Idose 22)

Label for iDose TR (travoprost intracameral implant) 75 mcg by Glaukos Corporation. The label states the product is a sterile, single-dose intracameral implant with storage instructions at 2°C to 25°C and a caution not to use if the package is damaged. The label includes the NDC number 25357-100-01 and is marked Rx only.*

FDA Label Image

75 Mcg Carton Label (Idose 23)

Box packaging label for iDose TR (travoprost intracameral implant) 75 mcg by Glaukos Corporation. The label features a blue swirl design and text including the proprietary and generic names, dosage strength, and route (intracameral implant). It also includes storage instructions, contents details, and a barcode placeholder, with the labeler address in San Clemente, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.